Protecting Kids from Pneumonia Arlington VA

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Arlington.

Parag Bhattarai, MD
1410 N Scott St Apt 670
Arlington, VA
Specialties
Pediatrics
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Robert B Kugel, MD, FAAP
(703) 527-7279
Apt 1016 900 N Taylor St
Arlington, VA
Specialties
Pediatrics
Gender
Male
Education
Graduation Year: 1946

Data Provided by:
Dr. Rebecca Jean Eick
(757) 470-4546
Apt 2 1611 28th St S
Arlington, VA
Specialty
Pediatrics

Dr. Noelle Elizabeth Bach Halloin
(314) 753-8223
828 S Irving St
Arlington, VA
Specialty
Pediatrics

Jodi Ilyse Pike, MD
(732) 207-5782
Apt 917 901 15th St S
Arlington, VA
Specialties
Pediatrics
Gender
Male
Education
Graduation Year: 2004

Data Provided by:
Dr. Raymond Laurent MD
(703) 933-1960
611 South Carlin Springs Road
Arlington, VA
 
Bondy Harold E MD
(703) 671-4720
611 South Carlin Springs Road Suite 203
Arlington, VA
 
Kristine Ann Herrell, MD
(703) 516-7018
Apt #1406 1301 N Courthouse Rd
Arlington, VA
Specialties
Pediatrics
Gender
Male
Education
Graduation Year: 2004

Data Provided by:
Brett William Goudie, MD
Arlington, VA
Specialties
Pediatrics
Gender
Male
Education
Medical School: Univ Of Pittsburgh Sch Of Med, Pittsburgh Pa 15261
Graduation Year: 2000

Data Provided by:
Clydette Linda Powell, MD
(703) 284-0439
Apt 902 1050 N Stuart St
Arlington, VA
Specialties
Pediatrics
Gender
Female
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1976

Data Provided by:
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com